| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Nov 16, 2023 | Wambeke David J. Chief Business Officer | Buy | Diamedica Therapeutics Inc. | DMAC | $2.46 | $49,200 | +3.66% |
| Jun 23, 2023 | Jun 26, 2023 | Wambeke David J. Chief Business Officer | Buy | Diamedica Therapeutics Inc. | DMAC | $3.91 | $150,003 | +7.03% |
| Apr 10, 2023 | Apr 11, 2023 | Wambeke David J. Chief Business Officer | Buy | Diamedica Therapeutics Inc. | DMAC | $1.6 | $750,000 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.